BriaCell Therapeutics Corp. (8BT)
FSX
Real-time Data
06:00 AM
Day's Range
3.2252 wk Range
2.22Overview - 8BT - BriaCell Therapeutics Corp.
Key Statistics
Valuation
Enterprise Value
5.54M
P/E (Trailing)
‪-0.07‬
PEG Ratio
‪0.00082‬
Price / Book
‪1.21‬
EV / EBITDA
‪-0.20‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-90.84%‬
Return on Equity
‪-175.25%‬
Ownership
Shares Outstanding
7.25M
Float
7.85M
Held by Insiders
‪0.50%‬
Held by Institutions
‪6.39%‬
Price stats
Beta
‪1.51‬
50-Day Avg
‪2.85‬
200-Day Avg
‪4.08‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 8BT - BriaCell Therapeutics Corp.
Peers - 8BT - BriaCell Therapeutics Corp.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 8BTFSXBriaCell Therapeutics Corp.28.18MMarket Cap-66.94%52-week change-0.07P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE56.27BMarket Cap+30.57%52-week change39.07P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.37.93BMarket Cap+83.17%52-week change-30.35P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.29BMarket Cap+16.03%52-week change65.41P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 8BT - BriaCell Therapeutics Corp.
About
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company specializing in developing novel immunotherapies to transform cancer care. The company focuses on cell-based cancer immunotherapies designed to harness and direct the immune system against tumors, with initial emphasis on metastatic breast cancer…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
